Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
Howard Hughes
HHH
$4.02B
| $2.03M | ﹤0.01% |
17,177
-2,886
| -14% | -$363K |
|
|
HIMX
2827
CALL
Himax Technologies
HIMX
$2.64B
| $2.03M | ﹤0.01% |
345,800
-17,700
| -5% | -$118K |
|
2828
Materion
MTRN
$5.91B
| $2.03M | ﹤0.01% |
33,591
+19,427
| +137% | +$1.17M |
|
2829
Visteon
VC
$2.83B
| $2.03M | ﹤0.01% |
21,846
-79,202
| -78% | -$9.16M |
|
2830
MBIA
MBI
$254M
| $2.03M | ﹤0.01% |
189,590
+10,388
| +6% | +$106K |
|
2831
CALL
Trane Technologies
TT
$106B
| $2.03M | ﹤0.01% |
19,800
-6,600
| -25% | -$645K |
|
|
RDC
2832
DELISTED
Rowan Companies Plc
RDC
| $2.02M | ﹤0.01% |
107,523
-147,912
| -58% | -$2.22M |
|
|
CRC
2833
CALL
DELISTED
California Resources Corporation
CRC
| $2.02M | ﹤0.01% |
41,700
+5,300
| +15% | +$204K |
|
|
TRHC
2834
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $2.02M | ﹤0.01% |
24,885
+11,888
| +91% | +$871K |
|
|
CBL
2835
DELISTED
CBL& Associates Properties, Inc.
CBL
| $2.02M | ﹤0.01% |
506,349
+184,607
| +57% | +$885K |
|
2836
Madrigal Pharmaceuticals
MDGL
$12.2B
| $2.02M | ﹤0.01% |
9,430
-10,516
| -53% | -$2.64M |
|
2837
HUB Group
HUBG
$2.58B
| $2.02M | ﹤0.01% |
88,442
+6,046
| +7% | +$150K |
|
|
SONC
2838
CALL
DELISTED
Sonic Corp
SONC
| $2.02M | ﹤0.01% |
46,500
+40,700
| +702% | +$1.46M |
|
|
TLRD
2839
DELISTED
Tailored Brands, Inc.
TLRD
| $2.01M | ﹤0.01% |
79,961
+18,685
| +30% | +$429K |
|
|
BRS
2840
CALL
DELISTED
Bristow Group, Inc.
BRS
| $2.01M | ﹤0.01% |
166,000
+1,000
| +0.6% | +$12.4K |
|
2841
Mueller Industries
MLI
$14.9B
| $2.01M | ﹤0.01% |
277,624
+191,292
| +222% | +$1.47M |
|
2842
CALL
Hershey
HSY
$37.4B
| $2.01M | ﹤0.01% |
19,700
-3,100
| -14% | -$306K |
|
|
SGMO
2843
CALL
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $2.01M | ﹤0.01% |
118,500
+68,900
| +139% | +$1.05M |
|
2844
Zumiez
ZUMZ
$319M
| $2M | ﹤0.01% |
76,147
-66,814
| -47% | -$1.75M |
|
|
TEN
2845
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $2M | ﹤0.01% |
47,599
+34,941
| +276% | +$1.53M |
|
|
SNP
2846
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
| $2M | ﹤0.01% |
19,947
+1,881
| +10% | +$178K |
|
2847
CALL
Ball Corp
BALL
$16.5B
| $2M | ﹤0.01% |
45,500
+38,800
| +579% | +$1.58M |
|
2848
PUT
Infosys
INFY
$49.4B
| $2M | ﹤0.01% |
196,600
+37,200
| +23% | +$378K |
|
2849
Canadian Natural Resources
CNQ
$97.4B
| $2M | ﹤0.01% |
124,911
-101,490
| -45% | -$1.72M |
|
2850
Enerpac Tool Group
EPAC
$1.89B
| $2M | ﹤0.01% |
71,536
+46,744
| +189% | +$1.35M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.